Does ALPHA.1-PROTEINASE INHIBITOR HUMAN Cause Product dose omission issue? 397 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 397 reports of Product dose omission issue have been filed in association with ALPHA.1-PROTEINASE INHIBITOR HUMAN (GLASSIA). This represents 5.6% of all adverse event reports for ALPHA.1-PROTEINASE INHIBITOR HUMAN.
397
Reports of Product dose omission issue with ALPHA.1-PROTEINASE INHIBITOR HUMAN
5.6%
of all ALPHA.1-PROTEINASE INHIBITOR HUMAN reports
45
Deaths
203
Hospitalizations
How Dangerous Is Product dose omission issue From ALPHA.1-PROTEINASE INHIBITOR HUMAN?
Of the 397 reports, 45 (11.3%) resulted in death, 203 (51.1%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPHA.1-PROTEINASE INHIBITOR HUMAN. However, 397 reports have been filed with the FAERS database.
What Other Side Effects Does ALPHA.1-PROTEINASE INHIBITOR HUMAN Cause?
Dyspnoea (1,011)
Pneumonia (681)
Fatigue (669)
Headache (631)
Death (456)
Cough (447)
Nausea (385)
Malaise (367)
Dizziness (314)
Pain (287)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ALPHA.1-PROTEINASE INHIBITOR HUMAN Alternatives Have Lower Product dose omission issue Risk?
ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALPRAZOLAM
ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALPROSTADIL
ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALTEPLASE
ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALTERNARIA ALTERNATA
ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALTHIAZIDE